AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
LRCX
ACCE-researched

Lam Research Corporation Common Stock (LRCX) fair value

Technology · Semiconductor Equipment & Materials · NASDAQ · United States
$230.10-0.02%
Market cap $288.0BNext earnings 2026-10-21Updated Oct 23, 2026
Our verdict
Trades 47% above our fair value
Price
$230.10
Model fair valueConfidence: good
$156
Model range
$79.22 to $246
Fair value $156
Price $230
2 models fit Lam Research Corporation Common Stock and they disagree: 0 of 2 land within 15% of the average.
Two or more of our models back this value.
Large premium(i)Bronze45
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionLam Research Corporation Common Stock (LRCX)
Fair value (2 models)
$156
ACCE price target
$247
Rating
Overvalued
Horizon
12 months
Fair value published on 23 Oct 2026, 12:04 CEST; previously $143 since 21 Oct 2026, 11:06 CEST.
ACCE price target published on 22 Oct 2026, 01:52 CEST; previously $340 since 3 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 11:06 CEST.
Price used: $230 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
47.4% above
-32.2% to fair value
ACCE score
65
out of 100
Analysts
83% buy
35 covering
P/E
40.0x
forward 33.7x
1-year return
+56.0%
Dividend yield
0.40%

Lam Research Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Lam Research makes the etch and deposition tools that cut and layer the transistor structures inside advanced logic and memory chips, and it sells a large share of its revenue into wafer fab expansion at TSMC, Samsung and the memory makers. Its moat rests on process know-how and installed-base service: once a fab qualifies a Lam etch step, switching tools means requalifying a process that runs on millions of wafers, which keeps share sticky and supports a 50.5% gross margin. The near-term driver is the shift to gate-all-around transistors and higher-layer-count 3D NAND, both of which require more etch and deposition steps per wafer than the previous generation. Revenue growth of 30.0% and a 37.4% operating margin show that this demand is already reaching the income statement rather than sitting in backlog. At 33.7 times forward earnings against 52.3 times trailing, the market is pricing in a sharp step-up in profit that the company has yet to deliver, so the thesis depends on whether the forward numbers hold through the next capex cycle. Worth a deeper look to test that durability against wafer fab equipment spending plans for the next two years.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Valuation stretched vs model
    Shares trade 47.4% above the model fair value of $156.11. Forward P/E of 33.7 and EV/EBITDA of 43.2 leave little room for an earnings miss.
  • moderate
    Insider selling, no buying
    Last 10 disclosed insider transactions were $46.63M in sales and $0.00M in buys. Insiders hold only 0.3% of shares.
  • moderate
    ACCE score down 9 points
    Score fell from 74 to 65 over 90 days, with Valuation at 35 and Momentum at 46 dragging the composite despite Quality at 92.

AI research notes

AI-assisted·How I use AIWritten Oct 24, 2026 · figures from 2026-10-23 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 30.0% year over year, far faster than the 9.7% yearly average of the last five years.
  • Lam earns a 31.3% net margin and a 35.9% return on invested capital, which are strong returns on the money it deploys.
  • The diluted share count fell 2.3% last fiscal year, so each share now represents a slightly larger slice of the business.
Why it could disappoint
  • At a $230.10 share price, the stock trades 47.4% above the model fair value of $156.11.
  • Its 40.0x trailing P/E sits well above the sector median forward P/E of 25.9x, leaving little room for disappointment.
  • Only 2 of the 5 valuation models in the consensus were usable, so the fair value rests on a thin base.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where LRCX's valuation models land
Price
$230.10
Model fair value
$156
Model range
$79.22 to $246
Fair value $156
Price $230
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish83% buy · 35 covering analysts
● Strong buy 25● Buy 4● Hold 6● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
0 buys · 3 sells
Since Apr 27, 2026, 1 member
Average delay
5 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-12.8%
1 month
-25.1%
3 months
-24.6%
6 months
-14.1%
YTD
+34.4%
1 year
+56.0%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 12:04 CESTFair value$156$143$230
22 Oct 2026, 01:52 CESTACCE price target$247$340$261
21 Oct 2026, 11:06 CESTRatingOvervaluedfirst publication$263
21 Oct 2026, 11:06 CESTFair value$143$147$263
17 Oct 2026, 00:00 CESTFair value$147$151$277
12 Oct 2026, 00:00 CESTFair value$151$160$319
3 Oct 2026, 00:00 CESTACCE price target$340first publication$347
1 Oct 2026, 00:00 CESTFair value$160$162$324
24 Sept 2026, 00:00 CESTFair value$162$157$311
22 Sept 2026, 00:00 CESTFair value$157$161$288

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full LRCX page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth88Value35Quality92Momentum46Total65
Valuation
Trailing P/E
40.0x
Forward P/E
33.7x
PEG
1.45
P/B
31.20x
EV / Revenue
16.5x
Book value/sh
$9.97
Enterprise value
$382.7B
Profitability
ROE
65.1%
FCF yield
1.70%
ROIC
35.9%
Health and risk
Debt / equity
0.33
Dividend yield
0.40%
Beta
1.85

Member of

ACCE Smart MoneyACCE Semiconductors

Price

+51.7% · 1Y

Ask anything about LRCX

Answered from Lam Research Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 67% of peers
low 32.5x40.0xhigh 51.3x
ROEbetter than 50% of peers
low 36%65%high 88%
Div yieldbetter than 33% of peers
low 0.1%0.4%high 0.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
LRCX Lam Research Corporation Common Stock$230.10$15647% above40.0x65.1%9265
AMAT Applied Materials Inc. Common Stock$375.58$22070% above32.5x41.1%9267
KLAC KLA Corporation Common Stock$147.83$9063% above44.7x87.5%9159
6857.T Advantest Corporation¥32370.00--51.3x56.9%10077
ASML ASML Holding N.V. New York Registry Shares$1560.54$89774% above38.4x65.6%9675
ASML.AS ASML Holding€1419.60€80177% above40.2x65.6%9677
TER Teradyne Inc. Common Stock$308.75$102202% above47.4x36.5%9667

Sector report card

Where LRCX ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Sep 30, 2026
    Lam Research Corporation Announces September Quarter Financial Conference Call
  • GlobeNewswire•Sep 28, 2026
    Virtualware completes the acquisition of British company Virtalis
  • GlobeNewswire•Sep 28, 2026
    High-K Dielectric Materials Market - Global Strategic Business Report: Capture 48% market expansion to $262.4M by 2030 as GAA, AI and 3D memory reshape chip economics-benchmark Applied Materials, ASM International, Lam Research, Tokyo Electron before tariffs reset supply chains
5 more press releases · full archive on Investor+.INVESTOR
40 filings
September 2026
Sep 24
ProxyProxy statementPeriod 2026-11-03
View on SEC →
Sep 10
Form 4Insider transactionPeriod 2026-09-09
View on SEC →
Sep 10
Form 4Insider transactionPeriod 2026-09-09
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR